- Home
- BMRN vs AES Comparison
BMRN vs AES Comparison
Compare BMRN & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMRN | AES |
|---|---|---|
| Founded | 1996 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 10.6B |
| IPO Year | 1999 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BMRN | AES |
|---|---|---|
| Price | $56.74 | $14.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 28 | 9 |
| Target Price | ★ $90.78 | $15.00 |
| AVG Volume (30 Days) | 2.4M | ★ 9.1M |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 4.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.14 | ★ 2.04 |
| Revenue | $1,313,646,000.00 | ★ $12,233,000,000.00 |
| Revenue This Year | $20.05 | $7.93 |
| Revenue Next Year | $14.91 | $1.78 |
| P/E Ratio | $415.29 | ★ $7.32 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $13.28 |
| 52 Week High | $70.98 | $17.65 |
Technical Indicators
Market Signals| Indicator | BMRN | AES |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 50.89 |
| Support Level | $53.19 | $14.83 |
| Resistance Level | $58.39 | $15.03 |
| Average True Range (ATR) | 1.85 | 0.05 |
| MACD | 0.33 | -0.01 |
| Stochastic Oscillator | 63.97 | 45.45 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES owns a majority stake and operates six electric utilities, distributing power to more than 2.5 million customers.